Heartflow (NASDAQ:HTFL) Trading 6.1% Higher – What’s Next?

Heartflow, Inc. (NASDAQ:HTFL) traded up 6.1% on Monday . The company traded as high as $29.76 and last traded at $29.21. 139,429 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 468,548 shares. The stock had previously closed at $27.53.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HTFL. Stifel Nicolaus upped their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Piper Sandler assumed coverage on Heartflow in a report on Tuesday, September 2nd. They issued an “overweight” rating and a $38.00 target price for the company. Wall Street Zen upgraded Heartflow to a “hold” rating in a research report on Saturday, August 16th. Canaccord Genuity Group raised their price target on shares of Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Finally, JPMorgan Chase & Co. lifted their target price on Heartflow from $36.00 to $40.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Four investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Heartflow presently has a consensus rating of “Hold” and a consensus target price of $38.60.

Heartflow Trading Up 4.4%

The firm has a 50 day moving average price of $33.46.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Friday, September 19th. The company reported ($1.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($1.26). The business had revenue of $43.42 million during the quarter, compared to the consensus estimate of $43.20 million.

Hedge Funds Weigh In On Heartflow

Several large investors have recently bought and sold shares of HTFL. TFC Financial Management Inc. acquired a new position in Heartflow in the third quarter valued at $40,000. Emerald Mutual Fund Advisers Trust purchased a new position in Heartflow in the 3rd quarter valued at $4,418,000. TrueMark Investments LLC purchased a new position in Heartflow during the third quarter worth about $918,000. Baillie Gifford & Co. purchased a new position in shares of Heartflow during the 3rd quarter worth approximately $101,182,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in Heartflow in the third quarter valued at $234,000.

About Heartflow

We have pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease (“CAD”), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.